Repligen Corporation (RGEN)

RGEN trades at $125.61, 14.2% above the near-term max pain of $110 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($65-$170), reflecting growing call interest at higher strikes. Key magnetic zone at 110 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for RGEN shows an upward trend from 65 to 170, suggesting bullish positioning in longer-dated options. The 86% spread signals divergent expectations across timeframes. Levels distributed around 125.61. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.